危重症幸存者急性肾损伤与后续衰弱状态:一项二次分析
该研究为前瞻性队列研究的二次分析,纳入美国一家三级医疗中心内科/外科ICU中317例呼吸衰竭和/或休克患者,按KDIGO分期判定急性肾损伤,用临床衰弱量表在出院后3个月和12个月评估衰弱状态。校正ICU平均SOFA评分、APACHE II评分、Charlson合并症指数、肾功能和基线临床衰弱量表评分后,急性肾损伤1、2、3期与3个月时更高的衰弱评分相关(OR分别为1.92、2.40、4.41)。12个月时类似关联仍存在(OR分别为1.87、1.81、2.76)。作者认为急性肾损伤可预测危重症幸存者出院后3个月和12个月更差的衰弱状态,对临床决策有重要意义。
要点
- 317例呼吸衰竭和/或休克ICU幸存者中,243例(77%)发生急性肾损伤,急性肾损伤患者中四分之一在基线即存在衰弱。
- 校正SOFA、APACHE II、Charlson合并症指数、肾功能和基线临床衰弱量表评分后,急性肾损伤1、2、3期与3个月时更高衰弱评分相关,OR分别为1.92(95%CI 1.14-3.24)、2.40(95%CI 1.31-4.42)、4.41(95%CI 2.20-8.82)。
- 12个月时急性肾损伤1、2、3期与更高临床衰弱量表评分的关联分别为OR 1.87(95%CI 1.11-3.14)、OR 1.81(95%CI 0.94-3.48)、OR 2.76(95%CI 1.34-5.66),其中2期未达统计学显著。
- 补充分析和敏感性分析观察到类似的关联模式。
- 作者认为这些发现对急性肾损伤幸存者的临床决策有重要影响,并强调需要理解衰弱的驱动因素以改善以患者为中心的结局。
适用人群与场景
- 美国一家三级医疗中心内科/外科ICU中317例呼吸衰竭和/或休克患者。
- 该分析为前瞻性队列研究的二次分析,无干预措施。
诊断标准与关键阈值
- 急性肾损伤采用肾脏病改善全球结局(KDIGO)分期判定。
- 衰弱状态采用临床衰弱量表在出院后3个月和12个月评估。
研究设计与关键结果
- 研究类型:前瞻性队列研究的二次分析;样本量317例;人群为呼吸衰竭和/或休克的ICU幸存者;无干预。
- 317例中243例(77%)发生急性肾损伤,急性肾损伤患者中四分之一在基线存在衰弱。
- 校正平均ICU SOFA评分、APACHE II评分、Charlson合并症指数、肾功能和基线临床衰弱量表评分后,急性肾损伤1、2、3期与3个月时更高衰弱评分相关,OR分别为1.92(95%CI 1.14-3.24)、2.40(95%CI 1.31-4.42)、4.41(95%CI 2.20-8.82)。
- 12个月时急性肾损伤1、2、3期与更高临床衰弱量表评分的OR分别为1.87(95%CI 1.11-3.14)、1.81(95%CI 0.94-3.48)、2.76(95%CI 1.34-5.66)。
- 补充分析和敏感性分析观察到类似的关联模式。
证据类型、等级与局限
- 证据类型:前瞻性队列研究的二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为急性肾损伤可预测危重症幸存者出院后3个月和12个月更差的衰弱状态,这些发现对急性肾损伤幸存者的临床决策有重要影响。
- 作者强调需要理解衰弱的驱动因素以改善以患者为中心的结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Acute kidney injury frequently complicates critical illness and is associated with high morbidity and mortality. Frailty is common in critical illness survivors, but little is known about the impact of acute kidney injury. We examined the association of acute kidney injury and frailty within a year of hospital discharge in survivors of critical illness.
DESIGN: Secondary analysis of a prospective cohort study.
SETTING: Medical/surgical ICU of a U.S. tertiary care medical center.
PATIENTS: Three hundred seventeen participants with respiratory failure and/or shock.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Acute kidney injury was determined using Kidney Disease Improving Global Outcomes stages. Clinical frailty status was determined using the Clinical Frailty Scale at 3 and 12 months following discharge. Covariates included mean ICU Sequential Organ Failure Assessment score and Acute Physiology and Chronic Health Evaluation II score as well as baseline comorbidity (i.e., Charlson Comorbidity Index), kidney function, and Clinical Frailty Scale score. Of 317 patients, 243 (77%) had acute kidney injury and one in four patients with acute kidney injury was frail at baseline. In adjusted models, acute kidney injury stages 1, 2, and 3 were associated with higher frailty scores at 3 months (odds ratio, 1.92; 95% CI, 1.14-3.24; odds ratio, 2.40; 95% CI, 1.31-4.42; and odds ratio, 4.41; 95% CI, 2.20-8.82, respectively). At 12 months, a similar association of acute kidney injury stages 1, 2, and 3 and higher Clinical Frailty Scale score was noted (odds ratio, 1.87; 95% CI, 1.11-3.14; odds ratio, 1.81; 95% CI, 0.94-3.48; and odds ratio, 2.76; 95% CI, 1.34-5.66, respectively). In supplemental and sensitivity analyses, analogous patterns of association were observed.
CONCLUSIONS: Acute kidney injury in survivors of critical illness predicted worse frailty status 3 and 12 months postdischarge. These findings have important implications on clinical decision making among acute kidney injury survivors and underscore the need to understand the drivers of frailty to improve patient-centered outcomes.
参考来源
- Abdel-Kader K, Girard TD, Brummel NE, et al. Acute Kidney Injury and Subsequent Frailty Status in Survivors of Critical Illness: A Secondary Analysis. Crit Care Med. 2018. PMID: 29373362. doi:10.1097/CCM.0000000000003003
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。